Annual SG&A
$173.61 M
-$4.37 M-2.45%
31 December 2023
Summary:
Cytokinetics Incorporated annual selling, general & administrative expenses is currently $173.61 million, with the most recent change of -$4.37 million (-2.45%) on 31 December 2023. During the last 3 years, it has risen by +$120.79 million (+228.69%). CYTK annual SG&A is now -2.45% below its all-time high of $177.98 million, reached on 31 December 2022.CYTK Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$56.65 M
+$5.83 M+11.47%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly selling, general & administrative expenses is currently $56.65 million, with the most recent change of +$5.83 million (+11.47%) on 30 September 2024. Over the past year, it has increased by +$16.54 million (+41.24%). CYTK quarterly SG&A is now at all-time high.CYTK Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$9.30 B
-$576.40 M-6.61%
30 September 2024
Summary:
Cytokinetics Incorporated TTM selling, general & administrative expenses is currently -$9.30 billion, with the most recent change of -$576.40 million (-6.61%) on 30 September 2024. Over the past year, it has dropped by -$9.49 billion (-5170.70%). CYTK TTM SG&A is now -9789.09% below its all-time high of $197.09 million, reached on 30 September 2024.CYTK TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.5% | +41.2% | -5170.7% |
| 3 y3 years | +228.7% | +116.2% | -10000.0% |
| 5 y5 years | +455.0% | +480.9% | -10000.0% |
CYTK Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2.5% | +228.7% | at high | +116.2% | -115.9% | at low |
| 5 y | 5 years | -2.5% | +455.0% | at high | +480.9% | -194.8% | at low |
| alltime | all time | -2.5% | +5021.3% | at high | +2189.0% | -9789.1% | at low |
Cytokinetics Incorporated Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $56.65 M(+11.5%) | $197.09 M(+9.2%) |
| June 2024 | - | $50.82 M(+11.7%) | $180.55 M(+6.6%) |
| Mar 2024 | - | $45.50 M(+3.1%) | $169.45 M(-2.4%) |
| Dec 2023 | $173.61 M(-2.5%) | $44.11 M(+10.0%) | $173.61 M(-5.4%) |
| Sept 2023 | - | $40.11 M(+1.0%) | $183.47 M(-4.2%) |
| June 2023 | - | $39.72 M(-20.0%) | $191.58 M(-1.5%) |
| Mar 2023 | - | $49.66 M(-8.0%) | $194.57 M(+9.3%) |
| Dec 2022 | $177.98 M(+83.9%) | $53.97 M(+11.9%) | $177.98 M(+12.8%) |
| Sept 2022 | - | $48.22 M(+12.9%) | $157.81 M(+16.2%) |
| June 2022 | - | $42.72 M(+29.2%) | $135.79 M(+18.8%) |
| Mar 2022 | - | $33.07 M(-2.2%) | $114.28 M(+18.0%) |
| Dec 2021 | $96.80 M(+83.3%) | $33.81 M(+29.0%) | $96.80 M(+25.9%) |
| Sept 2021 | - | $26.20 M(+23.6%) | $76.91 M(+22.1%) |
| June 2021 | - | $21.20 M(+35.9%) | $63.01 M(+12.6%) |
| Mar 2021 | - | $15.60 M(+12.2%) | $55.97 M(+6.0%) |
| Dec 2020 | $52.82 M(+33.4%) | $13.91 M(+13.1%) | $52.82 M(+6.7%) |
| Sept 2020 | - | $12.30 M(-13.1%) | $49.50 M(+5.4%) |
| June 2020 | - | $14.16 M(+13.8%) | $46.95 M(+10.1%) |
| Mar 2020 | - | $12.45 M(+17.6%) | $42.62 M(+7.6%) |
| Dec 2019 | $39.61 M(+26.6%) | $10.58 M(+8.5%) | $39.61 M(+8.3%) |
| Sept 2019 | - | $9.75 M(-0.8%) | $36.58 M(+7.6%) |
| June 2019 | - | $9.84 M(+4.2%) | $33.99 M(+5.6%) |
| Mar 2019 | - | $9.44 M(+24.9%) | $32.20 M(+0.5%) |
| Dec 2018 | $31.28 M(-14.2%) | $7.56 M(+5.5%) | $32.03 M(-7.8%) |
| Sept 2018 | - | $7.16 M(-11.0%) | $34.73 M(-6.7%) |
| June 2018 | - | $8.05 M(-13.1%) | $37.23 M(-1.0%) |
| Mar 2018 | - | $9.26 M(-9.7%) | $37.62 M(+3.2%) |
| Dec 2017 | $36.47 M(+31.1%) | $10.26 M(+6.2%) | $36.47 M(+10.9%) |
| Sept 2017 | - | $9.66 M(+14.4%) | $32.88 M(+8.0%) |
| June 2017 | - | $8.44 M(+4.0%) | $30.44 M(+4.6%) |
| Mar 2017 | - | $8.12 M(+21.6%) | $29.10 M(+4.6%) |
| Dec 2016 | $27.82 M(+41.5%) | $6.67 M(-7.5%) | $27.82 M(+4.3%) |
| Sept 2016 | - | $7.22 M(+1.8%) | $26.68 M(+7.8%) |
| June 2016 | - | $7.09 M(+3.6%) | $24.74 M(+11.7%) |
| Mar 2016 | - | $6.84 M(+23.7%) | $22.14 M(+12.6%) |
| Dec 2015 | $19.67 M(+13.9%) | $5.53 M(+4.8%) | $19.67 M(+5.2%) |
| Sept 2015 | - | $5.28 M(+17.4%) | $18.70 M(+7.4%) |
| June 2015 | - | $4.50 M(+2.9%) | $17.41 M(+0.2%) |
| Mar 2015 | - | $4.37 M(-4.2%) | $17.38 M(+0.6%) |
| Dec 2014 | $17.27 M(+14.4%) | $4.56 M(+14.1%) | $17.27 M(+2.8%) |
| Sept 2014 | - | $3.99 M(-10.4%) | $16.80 M(+2.2%) |
| June 2014 | - | $4.46 M(+4.7%) | $16.45 M(+4.6%) |
| Mar 2014 | - | $4.26 M(+4.1%) | $15.72 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $15.09 M(+21.4%) | $4.09 M(+12.6%) | $15.09 M(+1.9%) |
| Sept 2013 | - | $3.63 M(-2.5%) | $14.81 M(+4.5%) |
| June 2013 | - | $3.73 M(+2.6%) | $14.17 M(+8.9%) |
| Mar 2013 | - | $3.63 M(-4.7%) | $13.01 M(+4.7%) |
| Dec 2012 | $12.43 M(-8.5%) | $3.81 M(+27.5%) | $12.43 M(+8.3%) |
| Sept 2012 | - | $2.99 M(+16.5%) | $11.48 M(-1.8%) |
| June 2012 | - | $2.57 M(-16.0%) | $11.69 M(-12.2%) |
| Mar 2012 | - | $3.06 M(+6.7%) | $13.31 M(-2.1%) |
| Dec 2011 | $13.59 M(-4.3%) | $2.86 M(-10.6%) | $13.59 M(-4.9%) |
| Sept 2011 | - | $3.20 M(-23.5%) | $14.30 M(-1.4%) |
| June 2011 | - | $4.19 M(+25.5%) | $14.51 M(+5.9%) |
| Mar 2011 | - | $3.34 M(-6.6%) | $13.70 M(-3.5%) |
| Dec 2010 | $14.20 M(-9.1%) | $3.57 M(+4.6%) | $14.20 M(-0.2%) |
| Sept 2010 | - | $3.41 M(+0.9%) | $14.23 M(-3.2%) |
| June 2010 | - | $3.38 M(-11.9%) | $14.70 M(-4.8%) |
| Mar 2010 | - | $3.84 M(+6.5%) | $15.44 M(-1.2%) |
| Dec 2009 | $15.63 M(+3.6%) | $3.60 M(-7.1%) | $15.63 M(+5.1%) |
| Sept 2009 | - | $3.88 M(-6.0%) | $14.87 M(+0.4%) |
| June 2009 | - | $4.13 M(+2.7%) | $14.81 M(-0.8%) |
| Mar 2009 | - | $4.02 M(+41.5%) | $14.94 M(-0.9%) |
| Dec 2008 | $15.08 M(-9.8%) | $2.84 M(-25.7%) | $15.08 M(-7.8%) |
| Sept 2008 | - | $3.83 M(-10.0%) | $16.34 M(-1.7%) |
| June 2008 | - | $4.25 M(+2.3%) | $16.63 M(+1.4%) |
| Mar 2008 | - | $4.16 M(+1.1%) | $16.39 M(-1.9%) |
| Dec 2007 | $16.72 M(+9.7%) | $4.11 M(-0.1%) | $16.72 M(+0.0%) |
| Sept 2007 | - | $4.11 M(+2.4%) | $16.72 M(+3.3%) |
| June 2007 | - | $4.01 M(-10.4%) | $16.18 M(+0.5%) |
| Mar 2007 | - | $4.48 M(+9.1%) | $16.10 M(+5.6%) |
| Dec 2006 | $15.24 M(+17.5%) | $4.11 M(+15.0%) | $15.24 M(+7.1%) |
| Sept 2006 | - | $3.57 M(-9.3%) | $14.24 M(+1.8%) |
| June 2006 | - | $3.94 M(+8.7%) | $13.99 M(+4.0%) |
| Mar 2006 | - | $3.62 M(+16.7%) | $13.46 M(+3.7%) |
| Dec 2005 | $12.97 M(+8.2%) | $3.10 M(-6.6%) | $12.98 M(-1.5%) |
| Sept 2005 | - | $3.33 M(-2.3%) | $13.17 M(-1.8%) |
| June 2005 | - | $3.40 M(+8.3%) | $13.42 M(+6.0%) |
| Mar 2005 | - | $3.14 M(-4.8%) | $12.66 M(+5.6%) |
| Dec 2004 | $11.99 M(+33.6%) | $3.30 M(-7.5%) | $11.99 M(+38.0%) |
| Sept 2004 | - | $3.57 M(+35.0%) | $8.69 M(+69.7%) |
| June 2004 | - | $2.64 M(+6.8%) | $5.12 M(+106.8%) |
| Mar 2004 | - | $2.48 M | $2.48 M |
| Dec 2003 | $8.97 M(+29.0%) | - | - |
| Dec 2002 | $6.95 M(+17.9%) | - | - |
| Dec 2001 | $5.90 M(+74.0%) | - | - |
| Dec 2000 | $3.39 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual SG&A year-on-year change?
- What is Cytokinetics Incorporated quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly SG&A year-on-year change?
- What is Cytokinetics Incorporated TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM SG&A year-on-year change?
What is Cytokinetics Incorporated annual selling, general & administrative expenses?
The current annual SG&A of CYTK is $173.61 M
What is the all time high annual SG&A for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual selling, general & administrative expenses is $177.98 M
What is Cytokinetics Incorporated annual SG&A year-on-year change?
Over the past year, CYTK annual selling, general & administrative expenses has changed by -$4.37 M (-2.45%)
What is Cytokinetics Incorporated quarterly selling, general & administrative expenses?
The current quarterly SG&A of CYTK is $56.65 M
What is the all time high quarterly SG&A for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly selling, general & administrative expenses is $56.65 M
What is Cytokinetics Incorporated quarterly SG&A year-on-year change?
Over the past year, CYTK quarterly selling, general & administrative expenses has changed by +$16.54 M (+41.24%)
What is Cytokinetics Incorporated TTM selling, general & administrative expenses?
The current TTM SG&A of CYTK is -$9.30 B
What is the all time high TTM SG&A for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM selling, general & administrative expenses is $197.09 M
What is Cytokinetics Incorporated TTM SG&A year-on-year change?
Over the past year, CYTK TTM selling, general & administrative expenses has changed by -$9.49 B (-5170.70%)